Bulletin
Investor Alert

Market Pulse Archives

July 13, 2020, 8:50 a.m. EDT

Enzo Biochem shares rise on FDA authorization for coronavirus test

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Enzo Biochem Inc. (ENZ)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Enzo Biochem Inc. /zigman2/quotes/203989318/composite ENZ +1.20% rallied 7.7% in premarket trading on Monday after the company said it received an emergency use authorization from the Food and Drug Administration for its COVID-19 diagnostic test. The regulator issued the EUA on July 7. It has granted emergency authorization to at least 137 diagnostic tests during the COVID-19 pandemic. Enzo's stock is up 8.7% year-to-date. The S&P 500 /zigman2/quotes/210599714/realtime SPX +0.06% has declined 1.4% since the start of the year.

/zigman2/quotes/203989318/composite
US : U.S.: NYSE
$ 2.53
+0.03 +1.20%
Volume: 284,636
Aug. 7, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$121.16 million
Rev. per Employee
$180,262
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,351.28
+2.12 +0.06%
Volume: 2.28B
Aug. 7, 2020 5:10p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.